Dropout — A Randomized Study to Abate Truancy and Violence in Grades 3-9 in Chicago Public Schools
Citation(s)
Allensworth, E M. & John Q. Easton (2007). "What Matters for Staying On-Track and Graduating in Chicago Public High Schools." Chicago, Consortium on Chicago School Research.
Christenson, S L, Sinclair M.F., Evelo D.L., and C.M. Hurley (1998) "Promoting school engagement with school using the Check & Connect model." Australian Journal of Guidance & Counseling, 9(1): 169-184.
Jacob, Brian and Jens Ludwig (2009). "Improving Educational Outcomes for Poor Children." In Changing Poverty, Changing Policies, edited by Maria Cancian and Sheldon Danziger. New York: Russell Sage Foundation.
Sinclair, M F., Christenson, S. L. and M. L. Thurlow. (2005). "Promoting school completion of urban secondary youth with emotional and behavioral disabilities." Exceptional Children, 71(4): 465-482.
Sinclair, M F., Christenson, S.L., Evelo D. L., and C.M. Hurley (1998). "Dropout prevention for youth with disabilities: Efficacy of a sustained school engagement procedure." Exceptional Children, 65(1): 7-21.
Preventing Truancy in Urban Schools Through Provision of Social Services by Truancy Officers
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
